---
schema_version: "secwatch.filing_event.v1"
accession: "0001162194-22-000022"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2022-03-16T23:59:59+00:00"
generated_at: "2026-06-26T22:16:29.457004+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Fluidigm CCO Colin McCracken resigns, effective June 12, 2022

## Summary
- Colin McCracken, Chief Commercial Officer, notified resignation on March 10, 2022.
- Departure effective June 12, 2022; he will assist with transition of responsibilities.
- No successor announced; role and duties to be covered during transition.

## SEC filing metadata
- accession: 0001162194-22-000022
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2022-03-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000116219422000022/0001162194-22-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000116219422000022/fldm-20220310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001162194-22-000022
- JSON: https://secwatch.observer/filing/0001162194-22-000022.json
- Plain text: https://secwatch.observer/filing/0001162194-22-000022.txt

## Key facts
- Executive change
  Colin McCracken resigned as Chief Commercial Officer at STANDARD BIOTOOLS INC..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On March 10, 2022, Colin McCracken, the Chief Commercial Officer of Fluidigm Corporation (the “Company”), notified the Company of his intention to resign, effective as of June 12, 2022, after assisting with the Company’s transition plan with respect to his role and responsibilities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000116219422000022/0001162194-22-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.